CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France
François Bertucci, Nadine Carbuccia, Séverine Garnier, Max Chaffanet & Daniel Birnbaum
Institute of Pathology, University Hospital Basel, Basel, Switzerland
Charlotte K. Y. Ng, Salvatore Piscuoglio & Maria R. De Filippo
Clarunis, Department of Biomedicine, University of Basel, Basel, Switzerland
Charlotte K. Y. Ng & Salvatore Piscuoglio
Inserm, U1232, Nantes, France
Anne Patsouris & Mario Campone
Institut de Cancérologie de l’Ouest - René Gauducheau, Saint Herblain, France
Anne Patsouris & Mario Campone
Genomic Core Facility UMS AMMICA Gustave Roussy Cancer Campus, Villejuif, France
Nathalie Droin
INSERM, US23, Villejuif, France
Nathalie Droin
CNRS, UMS3665, Villejuif, France
Nathalie Droin
Université Paris Sud, Orsay, France
Jean Charles Soria & Fabrice André
Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France
Jean Charles Soria
Bioinformatics Core Facility, Gustave Roussy Cancer Campus, Villejuif, France
Alicia Tran Dien, Yahia Adnani & Guillaume Meurice
Department of Translational Research, Institut Curie, Saint-Cloud, France
Maud Kamal
Unicancer, Paris, France
Marta Jimenez & Alexandra Jacquet
Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France
Semih Dogan, Benjamin Verret & Fabrice André
Centre Léon Bérard, Lyon, France
Thomas Bachelot
Centre Eugène Marquis, Rennes, France
Claudia Lefeuvre
Institut Bergonié, Bordeaux, France
Herve Bonnefoi
Institut Claudius-Regaud, IUCT-oncopôle, Toulouse, France
Florence Dalenc & Thomas Filleron
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Naveen Babbar
Department of Drug Development and Innovation, Institut Curie, Saint-Cloud, France
Christophe Le Tourneau
INSERM U900, Saint-Cloud, France
Christophe Le Tourneau
Versailles Saint Quentin en Yvelines University, Montigny le Bretonneux, France
Christophe Le Tourneau
Department of Medical Oncology, Gustave Roussy, Villejuif, France
Fabrice André